In the last trading session, 10.08 million shares of the Entero Therapeutics Inc. (NASDAQ:ENTO) were traded, and its beta was 1.33. Most recently the company’s share price was $0.60, and it changed around $0.25 or 72.12% from the last close, which brings the market valuation of the company to $1.95M. ENTO currently trades at a discount to its 52-week high of $14.51, offering almost -2318.33% off that amount. The share price’s 52-week low was $0.19, which indicates that the current value has risen by an impressive 68.33% since then. We note from Entero Therapeutics Inc.’s average daily trading volume that its 10-day average is 1.05 million shares, with the 3-month average coming to 561.07K.
Entero Therapeutics Inc. stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended ENTO as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Entero Therapeutics Inc. is expected to report earnings per share of -1.55 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Entero Therapeutics Inc. (NASDAQ:ENTO) trade information
Instantly ENTO has showed a green trend with a performance of 72.12% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.7499 on recent trading dayincreased the stock’s daily price by 19.99%. The company’s shares are currently down -85.72% year-to-date, but still up 74.48% over the last five days. On the other hand, Entero Therapeutics Inc. (NASDAQ:ENTO) is 48.33% up in the 30-day period. We can see from the shorts that 0.13 million shares have been sold at a short interest cover period of 0.42 day(s).
Entero Therapeutics Inc. (ENTO) estimates and forecasts
Entero Therapeutics Inc. share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -84.86 percent over the past six months and at a 97.64% annual growth rate that is well above the industry average of 17.60%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 95.90% in revenue this quarter, and will report an increase of 96.50% in the next quarter.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 73.53%.
ENTO Dividends
Entero Therapeutics Inc.’s next quarterly earnings report is expected to be released in November.
